U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014.

Cover of Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

Show details

ANNEX 1Suggestions for further reading and available training materials and tools

The references presented in this annex aim to provide additional sources of information on the most topical areas of programmatic management of drug-resistant TB (PMDT). These references do not necessarily reflect current WHO policies, and its contents are not necessarily endorsed by WHO.

Background

1.
Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.6) [PubMed: 23844450]
2.
Resolutions and decisions; annexes. Resolution WHA62.15. Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis; Sixty-second World Health Assembly; Geneva. 18–22 May 2009; Geneva: World Health Organization; 2009. [27 March 2014]. pp. 25–29. [30 April 2011] (WHA62/2009/REC/1) also available at: http://apps​.who.int/gb​/ebwha/pdf_files/WHA62-REC1​/WHA62_REC1-en.pdf.
3.
Global tuberculosis control report 2013. Geneva: World Health Organization; 2013. (WHO/HTM/TB/2013.11)
4.
Tuberculosis prevention, care and control: A practical directory of new advances. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.20)

Prevention and drug-resistant TB diagnosis, treatment and care

    Monitoring, detection, enrolment and treatment outcomes

    1.
    Drug-resistant tuberculosis: A survival guide for clinicians. 2nd edition. California: Curry International Tuberculosis Center and California Department of Public Health; 2008.
    2.
    Early detection of tuberculosis: An overview of approaches, guidelines and tools. Geneva: World Health Organization; 2011. (WHO/HTM/STB/PSI/2011.21)
    3.
    Electronic recording and reporting for tuberculosis care and control. Geneva: World Health Organization; 2012. (WHO/HTM/TB/2011.22)
    4.
    Multidrug-resistant tuberculosis (MDR-TB) indicators: a minimum set of indicators for the programmatic management of MDR-TB in national tuberculosis control programmes. Geneva: World Health Organization; 2010. (WHO/HTM/TB/2010.11)
    5.
    Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infectious Diseases. 2009;9(3):153–161. [PubMed: 19246019]

    Laboratory services

    1.
    Guidance for countries on the specifications for managing TB laboratory equipment and supplies. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.19)
    2.
    TB diagnostics and laboratory strengthening [website]. Geneva: World Health Organization; [27 March 2014]. http://www​.who.int/tb​/laboratory/tool_set/en/
    3.
    Policy framework for implementing new tuberculosis diagnostics. Geneva: World Health Organization; 2010. [24 March 2014]. http://www​.who.int/tb​/laboratory/whopolicyframework​_rev_june2011.pdf.
    4.
    Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system Policy statement. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.4)
    5.
    Commercial serodiagnostic tests for diagnosis of tuberculosis Policy statement. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.5) [PubMed: 26158189]
    6.
    Xpert MTB/RIF implementation manual Technical and operational ‘how-to’: practical considerations. Geneva: World Health Organization; 2014. (WHO/HTM/TB2014.1) [PubMed: 25473699]
    7.
    Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.422)
    8.
    Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. Geneva: World Health Organization; 2008. (WHO/HTM/TB/2008.392) [PubMed: 26290924]
    9.
    Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-Plus. Geneva: World Health Organization; 2001. (WHO/CDS/TB/2001.288)
    10.
    Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries. Policy statement. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.18) [PubMed: 26269875]
    11.
    Tuberculosis laboratory biosafety manual. Geneva: World Health Organization; 2012. [24 March 2014]. (WHO/HTM/TB/2012.11) http://apps​.who.int/iris​/bitstream/10665​/77949/1/9789241504638_eng.pdf. [PubMed: 24404640]
    12.
    Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. Geneva: World Health Organization; 2013. (WHO/HTM/TB/2013.14) [PubMed: 25473701]

    Treatment

    1.
    Treatment of tuberculosis: guidelines. 4th edition. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.420)
    2.
    PIH guide to the medical management of multidrug-resistant tuberculosis. 2nd edition. Boston: Partners In Health. USAID TB CARE II; 2014.
    3.
    Tuberculosis: Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries. Médecins Sans Frontières and Partners In Health; 2013.
    4.
    Caminero JA. Guidelines for clinical and operational management of drug-resistant tuberculosis. Paris: International Union Against Tuberculosis and Lung Disease; 2013.

    HIV and MDR-TB

    1.
    WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012. (WHO/HTM/TB/TB/2012.1) [PubMed: 23586124]
    2.
    Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013.
    3.
    Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011. (WHO/HTM/TB/2011.11)
    4.
    WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.419) [PubMed: 24432438]
    5.
    Policy guidelines for collaborative TB and HIV services for injecting and other drug users – an integrated approach. Geneva: World Health Organization; 2008. (WHO/HTM/TB/2008.404) [PubMed: 26447262]
    6.
    Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents – Recommendations for HIV-prevalent and resource-constrained settings. Geneva: World Health Organization; 2007. (WHO/HTM/TB/2007.379 & WHO/HIV/2007.1)
    7.
    A guide to monitoring and evaluation for collaborative TB/HIV activities. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.414)
    8.
    Operational guidance: Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations. Geneva: World Health Organization; 2012. (WHO/HTM/TB/2012/8)
    9.
    Implementation manual: Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations. Geneva: World Health Organization; 2013. (WHO/HTM/TB/2012/10)
    10.
    Working together with businesses – Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace. Geneva: World Health Organization; 2012. (WHO/HTM/TB/2012.3)
    11.
    Joint WHO/ILO policy guidelines on improving access to prevention, treatment and care services for HIV and TB. International Labour Organization and World Health Organization; 2010. (NLM classification: W 76) [PubMed: 26180899]

    Special situations

    1.
    Guidelines for control of tuberculosis in prisons. Tuberculosis Coalition for Technical Assistance and International Committee of the Red Cross; 2009.
    2.
    Tuberculosis care and control in refugee and displaced populations. Geneva: World Health Organization; 2007. (WHO/HTM/TB/2007.377)
    3.
    Management of multidrug-resistant tuberculosis in children: A field guide. Sentinel Project on Pediatric Drug-Resistant Tuberculosis/TB CARE II; 2012.

    Infection control

    1.
    WHO Policy on TB infection control in health-care facilities, congregate settings and households. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.419) [PubMed: 24432438]
    2.
    Implementing the WHO Policy on TB infection control in health-care facilities, congregate settings and households. Tuberculosis Coalition for Technical Assistance (TBCTA)/TB-Infection Control Sub-group of the Stop TB Partnership, USAID; [27 March 2014]. http://www​.stoptb.org​/wg/tb_hiv/assets/documents​/TBICImplementationFramework1288971813.pdf.

    Palliative and end-of-life care

    1.
    2.
    Ehospice: find a hospice. [27 March 2014]. http://www​.ehospice.com​/directory/findahospice.aspx.
    3.
    International Association for Hospice and Palliative Care: director of providers. [27 March 2014]. http://hospicecare​.com​/global-directory-of-providers-organizations/
    4.
    Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, et al. ATS end-of-life care task force. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. American Journal of Respiration and Critical Care Medicine. 2008;177(8):912–927. [PubMed: 18390964]
    5.
    Bourke SJ, Peel ET, editors. Integrated palliative care of respiratory disease. London: Springer-Verlag; 2013.
    6.
    Booth S, Dudgeon D, editors. Dyspnoea in advanced disease: a guide to clinical management. Oxford: Oxford University Press; 2006.
    7.
    Bond C, Lavy V, Wooldridge R. Palliative care toolkit: Improving care from the roots up in resource-limited settings. London: Help the Hospices; 2008. [24 March 2014]. http://www​.helpthehospices​.org.uk/our-services​/international​/what-we-do-internationally​/education-and-training​/palliative-care-toolkit/get/

Programmatic management of drug-resistant TB

1.
The Stop TB strategy Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva: World Health Organization; 2006. (WHO/HTM/TB/2006.368)
2.
A ministerial meeting of high M/XDR-TB burden countries: Meeting report Beijing, China. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2009.415)
3.
Airborne: A journey into the challenges and solutions to stopping MDR-TB and XDR-TB. Geneva: World Health Organization; 2009. (WHO/HTM/STB/2009.52)
4.
Public-private mix for TB care and control. a toolkit. Geneva: World Health Organization; 2010. (WHO/HTM/TB/2010.12)
5.
Public–private mix for TB care and control. Report of the seventh meeting of the subgroup on public–private mix for TB care and control. Geneva: World Health Organization; 2012.
6.
Community-based care for drug-resistant tuberculosis: A guide for implementers. USAID TB CARE II; 2011.
7.
Tuberculosis, ethics and human rights. Report of a regional workshop (6 October, 2013). Copenhagen: WHO Regional Office for Europe; 2014. [24 March 2014]. http://www​.euro.who.int​/__data/assets/pdf_file​/0004/242941/Tuberculosis,-ethics-and-human-rights.pdf.
Models of care for multidrug-resistant tuberculosis. Report of a regional workshop (17 October, 2013). Copenhagen: WHO Regional Office for Europe; 2014. [24 March 2014]. http://www​.euro.who.int​/__data/assets/pdf_file​/0005/242942/Models-of-care-for-multidrug-resistant-tuberculosis.pdf.
8.
Nutritional care and support for patients with tuberculosis. Guideline. Geneva: World Health Organization; 2013. [24 March 2014]. http://www​.who.int/nutrition​/publications​/guidelines/nutcare​_support_patients_with_tb/en/
9.
Best practices in prevention, control and care for drug-resistant tuberculosis. A resource for the continued implementation of the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015. Geneva: World Health Organization; 2013. [24 March 2014]. http://www​.euro.who.int​/en/publications/abstracts​/best-practices-in-prevention,-control-and-care-for-drug-resistant-tuberculosis. [PubMed: 25829287]

Human resources

1.
Planning the development of human resources for health for implementation of the Stop TB Strategy – A handbook. Geneva: World Health Organization; 2009. (WHO/HTM/TB/2008.407)
2.
Training for better TB control. Human resource development for TB control: a strategic approach within country support. Geneva: World Health Organization; 2002. (WHO/CDS/TB/2002.301)
3.
Assessment of human resources and time needed to implement the DOTS strategy for TB control in health facilities – survey instrument and guide to implementation. Geneva: World Health Organization; 2008. (WHO/HTM/TB/2008.395)

Drug procurement

1.
Global Drug Facility Product Catalogue. Geneva: World Heath Organization; [24 March 2014]. http://www​.stoptb.org​/gdf/drugsupply/drugs_available.asp.
2.
DR-TB drugs under the microscope: the sources and prices of medicines. IUATLD and MSF Access Campaign; 2013. [24 March 2014]. http://www​.theunion.org​/what-we-do/publications​/technical/english​/msf_tb_report_utm3rdedition-2013​_final.pdf.

Training materials and tools

1.
MDR-TB-Course. World Medical Association: free self-learning online tool accredited by the South African Medical Association and the Norwegian Medical Association. http://www​.wma.net/en​/70education/10onlinecourses​/10mdr_tb/index.html.
2.
Drug-resistant tuberculosis: A survival guide for clinicians. 2nd edition. California: Department of Public Health Curry International Tuberculosis Center; 2008.
3.
4.
MDR-TB Planning Toolkit. US Agency for International Development, World Health Organization; 2011. [24 March 2014]. http://www​.path.org/publications/detail​.php?i=1678.
5.
Management of tuberculosis: training for health facility staff. 2nd edition. Geneva: World Health Organization; 2010. (WHO/HTM/TB/2009.423a)
6.
Geneva: World Health Organization; 2004. Management of tuberculosis: training for health facility staff. How to organize training for health facility staff on TB control. (WHO/CDS/2004.332)
7.
Planning and budgeting for TB control activities. Geneva: World Health Organization; 2010. [24 March 2014]. http://www​.who.int/tb​/dots/planning_budgeting_tool​/faqs/en/index.html.
8.
Blasi F, Dara M, van der Werf MJ, Migliori GB. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. European Respiratory Journal. 2013;41(3):491–494. [PubMed: 23456928]

Useful websites

1.
2.
Global Drug Facility. http://www​.stoptb.org/gdf/
3.
Global Laboratory Initiative. http://www​.stoptb.org/wg/gli/default.asp.
4.
KNCV Tuberculosis Foundation. http://www​.kncvtbc.org/
5.
Medecins Sans Frontieres. http://www​.msf.org/
6.
Partners in Health. http://www​.pih.org/
7.
Systems for improved access to pharmaceuticals and services. http://siapsprogram​.org/
8.
Stop TB Partnership. http://www​.stoptb.org/
9.
10.
The International Union Against Tuberculosis and Lung Disease. http://www​.theunion.org/
11.
US CDC – Centers for Disease Control and Prevention. http://www​.cdc.gov/tb/
12.
World Health Organization, Stop TB Department. http://www​.who.int/tb/publications/en/
Copyright © World Health Organization 2014.

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution–should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK247417
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.2M)

In this Page

Other titles in this collection

Related information

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...